INO
INO
NASDAQ · Biotechnology

Inovio Pharmaceuticals Inc

$1.66
+0.10 (+6.41%)
As of Feb 8, 2:10 PM ET ·
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 27.68M 29.02M 30.84M
Net Income -234,624 -227,719 -278,307
EPS
Profit Margin -0.9% -0.8% -0.9%
Rev Growth +16.9% +16.9% +11.1%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 49.33M 56.78M 51.84M
Total Equity 78.84M 78.40M 79.95M
D/E Ratio 0.63 0.72 0.65
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA -236,384 -290,155 -260,150
Free Cash Flow -281,986 -255,634 -361,408